Shanghai Kehua Biological Engineering Overview
- Year Founded
-
1981
- Status
-
Public
- Employees
-
1,870
- Stock Symbol
-
002022
- Investments
-
7
- Share Price
-
$0.69
- (As of Friday Closing)
Shanghai Kehua Biological Engineering General Information
Description
Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in China. Its products are mainly offered in two primary business segments: Diagnostic Reagents and Diagnostic Laboratory Instruments. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits and lab-instruments comprising chemistry analyzers, microplate washers/readers, electrolyte analyzers, and nucleic acid extractors.
Contact Information
Website
www.skhb.comCorporate Office
- No. 1189 Qinzhou North Road
- Caohejing Emerging Technology Development Zone, Xuhui District
- Shanghai, 200233
- China
Corporate Office
- No. 1189 Qinzhou North Road
- Caohejing Emerging Technology Development Zone, Xuhui District
- Shanghai, 200233
- China
Shanghai Kehua Biological Engineering Stock Performance
As of 20-Nov-2026, Shanghai Kehua Biological Engineering’s stock price is $0.69. Its current market cap is $364M with 531M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.69 | $0.72 | $0.66 - $1.08 | $364M | 531M | 9.6M | -$0.19 |
Shanghai Kehua Biological Engineering Financials Summary
As of 30-Sep-2026, Shanghai Kehua Biological Engineering has a trailing 12-month revenue of $249M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 538,383 | 495,508 | 476,193 | 781,100 |
| Revenue | 249,094 | 228,398 | 245,169 | 343,197 |
| EBITDA | (97,232) | (77,374) | (65,168) | 6,097 |
| Net Income | (95,522) | (101,809) | (89,277) | (33,077) |
| Total Assets | 633,655 | 663,375 | 717,268 | 960,379 |
| Total Debt | 64,621 | 99,862 | 64,349 | 128,017 |
Shanghai Kehua Biological Engineering Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Shanghai Kehua Biological Engineering Comparisons
Industry
Financing
Details
Shanghai Kehua Biological Engineering Competitors (28)
One of Shanghai Kehua Biological Engineering’s 28 competitors is Guerbet Group, a Corporation company based in Villepinte, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Guerbet Group | Corporation | Villepinte, France | ||||
| Randox Laboratories | Corporation | Crumlin, United Kingdom | ||||
| Agappe Diagnostics | Formerly PE-Backed | Ernakulam, India | ||||
| Biocartis | Venture Capital-Backed | Mechelen, Belgium | ||||
| Abbott | Corporation | Abbot Park, IL |
Shanghai Kehua Biological Engineering Signals
Shanghai Kehua Biological Engineering Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Shanghai Kehua Biological Engineering Investments & Acquisitions (7)
Shanghai Kehua Biological Engineering’s most recent deal was a Early Stage VC with ArrayHope. The deal was made on 05-Sep-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ArrayHope | 05-Sep-2024 | Early Stage VC | Diagnostic Equipment | ||
| Xi'an TianLong Science and Technology | 28-Sep-2022 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
| Suzhou Tianlong Biotechnology | 29-Jun-2018 | Merger/Acquisition | Diagnostic Equipment | ||
| Xi'an TianLong Science and Technology | 11-Jun-2018 | Secondary Transaction - Private | Discovery Tools (Healthcare) | ||
| Igenesisbio | 21-Dec-2017 | Corporate | Diagnostic Equipment |
Shanghai Kehua Biological Engineering ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Shanghai Kehua Biological Engineering Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Xi'an TianLong Science and Technology | Xi'an, China | 1997 | |
| Suzhou Tianlong Biotechnology | Suzhou, China | 1997 |
Shanghai Kehua Biological Engineering FAQs
-
When was Shanghai Kehua Biological Engineering founded?
Shanghai Kehua Biological Engineering was founded in 1981.
-
Where is Shanghai Kehua Biological Engineering headquartered?
Shanghai Kehua Biological Engineering is headquartered in Shanghai, China.
-
What is the size of Shanghai Kehua Biological Engineering?
Shanghai Kehua Biological Engineering has 1,870 total employees.
-
What industry is Shanghai Kehua Biological Engineering in?
Shanghai Kehua Biological Engineering’s primary industry is Diagnostic Equipment.
-
Is Shanghai Kehua Biological Engineering a private or public company?
Shanghai Kehua Biological Engineering is a Public company.
-
What is Shanghai Kehua Biological Engineering’s stock symbol?
The ticker symbol for Shanghai Kehua Biological Engineering is 002022.
-
What is the current stock price of Shanghai Kehua Biological Engineering?
As of 20-Nov-2026 the stock price of Shanghai Kehua Biological Engineering is $0.69.
-
What is the current market cap of Shanghai Kehua Biological Engineering?
The current market capitalization of Shanghai Kehua Biological Engineering is $364M.
-
What is Shanghai Kehua Biological Engineering’s current revenue?
The trailing twelve month revenue for Shanghai Kehua Biological Engineering is $249M.
-
Who are Shanghai Kehua Biological Engineering’s competitors?
Guerbet Group, Randox Laboratories, Agappe Diagnostics, Biocartis, and Abbott are some of the 28 competitors of Shanghai Kehua Biological Engineering.
-
What is Shanghai Kehua Biological Engineering’s annual earnings per share (EPS)?
Shanghai Kehua Biological Engineering’s EPS for 12 months was -$0.19.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process